Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?

Qin, Kirby R; Mertens, Eveline; Tempo, Jake A; Perera, Marlon; Brennan, Janelle

Qin, Kirby R; Mertens, Eveline; Tempo, Jake A; Perera, Marlon; Brennan, Janelle.

Afiliação

Qin KR; Department of Urology, Bendigo Health, Bendigo, VIC, Australia.
Mertens E; School of Rural Health, Monash University, Bendigo, VIC, Australia.
Tempo JA; Department of Paediatrics, Monash University, Melbourne, VIC, Australia.
Perera M; Department of Urology, Bendigo Health, Bendigo, VIC, Australia.
Brennan J; Department of Urology, Austin Health, Melbourne, VIC, Australia.

Transl Androl Urol ; 13(5): 920-922, 2024 May 31.

Article em En | MEDLINE | ID: mdl-38855582

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Androl Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google